HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A N Boĭko Selected Research

Matrix Metalloproteinase 9 (Gelatinase B)

1/2014[von Willebrand factor and adhesion molecules in patients with multiple sclerosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A N Boĭko Research Topics

Disease

47Multiple Sclerosis
01/2014 - 01/2000
8Stroke (Strokes)
01/2013 - 01/2002
6Parkinson Disease (Parkinson's Disease)
01/2010 - 01/2003
5Relapsing-Remitting Multiple Sclerosis
01/2014 - 01/2002
5Ischemic Stroke
01/2012 - 01/2002
4Pain (Aches)
01/2009 - 01/2002
3Asthenia
01/2014 - 01/2010
3Atrophy
01/2013 - 01/2000
3Dyskinesias (Dyskinesia)
01/2010 - 01/2007
2Cognitive Dysfunction
01/2013 - 01/2009
2Brain Ischemia (Cerebral Ischemia)
01/2012 - 01/2005
2Tremor (Tremors)
01/2010 - 01/2009
2Disease Progression
01/2009 - 01/2006
2Optic Neuritis (Retrobulbar Neuritis)
09/2003 - 11/2002
2Hypertension (High Blood Pressure)
01/2003 - 01/2002
1Transient Global Amnesia
01/2014
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2014
1Back Pain (Backache)
01/2013
1Chronic Progressive Multiple Sclerosis
01/2013
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2012
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2012
1Ganglion Cysts (Ganglion)
01/2012
1Neurobehavioral Manifestations
01/2012
1Neurologic Manifestations (Neurological Manifestations)
01/2011
1Inflammation (Inflammations)
09/2010
1Mood Disorders (Mood Disorder)
01/2010

Drug/Important Bio-Agent (IBA)

8InterferonsIBA
01/2014 - 01/2000
5Neuroprotective AgentsIBA
01/2013 - 01/2006
5Glatiramer Acetate (Copaxone)FDA Link
01/2012 - 01/2002
5Interferon beta-1aFDA Link
01/2012 - 01/2003
4Levodopa (L Dopa)FDA LinkGeneric
01/2010 - 01/2007
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2014 - 09/2003
3Acetates (Acetic Acid Esters)FDA Link
01/2013 - 01/2009
3Interferon-betaIBA
01/2011 - 01/2000
3Dopamine Agonists (Dopamine Agonist)IBA
01/2010 - 01/2003
3Interferon beta-1b (Betaseron)FDA Link
01/2006 - 01/2000
2idebenoneIBA
01/2014 - 01/2013
2Biosimilar PharmaceuticalsIBA
01/2013 - 01/2012
2Myelin Basic ProteinIBA
05/2012 - 11/2003
2sitimagene ceradenovecIBA
01/2012 - 01/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2011 - 09/2010
2CTLA-4 AntigenIBA
11/2011 - 07/2002
2Betahistine (Serc)IBA
01/2011 - 01/2002
2Pramipexole (Mirapex)FDA LinkGeneric
01/2010 - 01/2009
2Carbidopa (Lodosyn)FDA LinkGeneric
01/2007 - 01/2004
2AntigensIBA
11/2003 - 01/2002
2eprosartan (Teveten)FDA Link
01/2003 - 01/2002
2Mesylates (Mesylate)IBA
01/2003 - 01/2002
2HLA-DRB1 Chains (HLA DRB1)IBA
11/2002 - 01/2000
1E-SelectinIBA
01/2014
1SelectinsIBA
01/2014
1P-SelectinIBA
01/2014
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2014
1Interferon Type IIBA
01/2014
1C-Reactive ProteinIBA
01/2014
1von Willebrand FactorIBA
01/2014
1Natalizumab (Tysabri)FDA Link
01/2014
1cerebrolysinIBA
01/2013
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2013
1ketoprofen lysineIBA
01/2013
1Ginkgo biloba extract (Rokan)IBA
01/2013
1laquinimodIBA
01/2013
1teriflunomideIBA
01/2013
1Alemtuzumab (Campath)FDA Link
01/2013
1Monoclonal AntibodiesIBA
01/2013
1SaltsIBA
01/2013
1Peptides (Polypeptides)IBA
05/2012
1Therapeutic UsesIBA
05/2012
1Liposomes (Liposome)IBA
05/2012
1Dopamine (Intropin)FDA LinkGeneric
01/2012
1Type A Botulinum Toxins (Botox)FDA Link
01/2012
1Protons (Proton)IBA
01/2012
1incobotulinumtoxinAFDA Link
01/2012
1Glycerylphosphorylcholine (Choline Alfoscerate)IBA
01/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2012
1antineoplaston A10 (A 10)IBA
01/2012
1Cytidine Diphosphate Choline (Citicoline)IBA
01/2012
1Retinaldehyde (Retinal)IBA
01/2012
1MelatoninIBA
01/2012
1CatecholaminesIBA
01/2012
1Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2011
1Interleukin-7 Receptor alpha SubunitIBA
11/2011
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
11/2011
1CCR5 Receptors (CCR5 Receptor)IBA
11/2011
1Histocompatibility Antigens Class IIIBA
11/2011
1ethylmethylhydroxypyridine succinateIBA
01/2011
1cytoflavinIBA
01/2011
1AntioxidantsIBA
01/2011
1Interferon-gamma (Interferon, gamma)IBA
09/2010
1Interleukin-6 (Interleukin 6)IBA
09/2010
1CytokinesIBA
09/2010
1rasagiline (Azilect)FDA Link
01/2010
1Monoamine Oxidase (MAO)IBA
01/2010
1TabletsIBA
01/2010
1Piracetam (Nootropil)IBA
01/2010

Therapy/Procedure

21Therapeutics
01/2014 - 01/2000
3Injections
01/2012 - 09/2003
1Aftercare (After-Treatment)
01/2013
1Subcutaneous Injections
01/2013
1Immunotherapy
11/2011